These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21924675)

  • 1. Population exposure to a novel influenza A virus over three waves of infection.
    Adamson WE; McGregor EC; Kavanagh K; McMenamin J; McDonagh S; Molyneaux PJ; Templeton KE; Carman WF
    J Clin Virol; 2011 Dec; 52(4):300-3. PubMed ID: 21924675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A(H1N1)2009 antibody seroprevalence in Scotland following the 2010/11 influenza season.
    Adamson WE; McGregor EC; Kavanagh K; McMenamin J; McDonagh S; Molyneaux PJ; Templeton KE; Carman WF
    Euro Surveill; 2011 May; 16(20):19871. PubMed ID: 21616049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of serum neutralization antibodies against seasonal influenza A strain H3N2 and the emerging strains 2009 H1N1 and avian H5N1.
    Zhang R; Rong X; Pan W; Peng T
    Scand J Infect Dis; 2011 Mar; 43(3):216-20. PubMed ID: 21142624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak.
    Adamson WE; Maddi S; Robertson C; McDonagh S; Molyneaux PJ; Templeton KE; Carman WF
    Euro Surveill; 2010 Jun; 15(24):. PubMed ID: 20576237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.
    Hung IF; To KK; Lee CK; Lin CK; Chan JF; Tse H; Cheng VC; Chen H; Ho PL; Tse CW; Ng TK; Que TL; Chan KH; Yuen KY
    Clin Infect Dis; 2010 Aug; 51(3):274-9. PubMed ID: 20575664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.
    Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W
    J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High titers of hemagglutination inhibition antibodies against 2009 H1N1 influenza virus in Southern Iran.
    Moghadami M; Moattari A; Tabatabaee HR; Mirahmadizadeh A; Rezaianzadeh A; Hasanzadeh J; Ebrahimi M; Zamiri N; Alborzi A; Bagheri Lankarani K
    Iran J Immunol; 2010 Mar; 7(1):39-48. PubMed ID: 20371918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.
    Kumar S; Fan J; Melzer-Lange M; Trost J; Havens PL; Willoughby RE; Chusid MJ; Henrickson KJ
    Pediatr Emerg Care; 2011 Sep; 27(9):804-7. PubMed ID: 21878831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.
    Hancock K; Veguilla V; Lu X; Zhong W; Butler EN; Sun H; Liu F; Dong L; DeVos JR; Gargiullo PM; Brammer TL; Cox NJ; Tumpey TM; Katz JM
    N Engl J Med; 2009 Nov; 361(20):1945-52. PubMed ID: 19745214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.
    Poeppl W; Poeppl G; Hunger M; Tobudic S; Winkler H; Faas A; Mooseder G; Burgmann H
    J Med Virol; 2012 Sep; 84(9):1331-4. PubMed ID: 22825809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroprevalence of pandemic influenza A (H1N1)pdm09 in two regions in Morocco following the 2010-2011 influenza season].
    El Rhaffouli H; El Boukhrissi F; Bajjou T; Laraqui A; Hilali F; Bahji M; El Harrak M; Lahlou Amine I
    Pathol Biol (Paris); 2013 Apr; 61(2):83-6. PubMed ID: 22728009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.
    Rizzo C; Rota MC; Bella A; Alfonsi V; Declich S; Caporali MG; Ranghiasci A; Lapini G; Piccirella S; Salmaso S; Montomoli E
    Vaccine; 2010 Apr; 28(20):3558-62. PubMed ID: 20307592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic influenza A/H1N1 2009 antibodies in the metropolitan area of Buenos Aires in Argentina.
    Labato MI; Contrini MM; Lazzarini D; Campos AM; Gauna ML; Claros R; López EL; Savy VL; Luna CM
    Int J Infect Dis; 2014 Feb; 19():20-5. PubMed ID: 24211378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic.
    Chao DY; Cheng KF; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Chan WC; Hsieh YH;
    Int J Infect Dis; 2011 Oct; 15(10):e695-701. PubMed ID: 21767970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009.
    Tsai TF; Pedotti P; Hilbert A; Lindert K; Hohenboken M; Borkowski A; Groth N; da Silva LJ; Kyaw MH
    Euro Surveill; 2010 Jul; 15(30):. PubMed ID: 20684814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological survey of 2009 H1N1 influenza in residents of Beijing, China.
    Deng Y; Pang XH; Yang P; Shi WX; Tian LL; Liu BW; Li S; Cui SJ; Li Y; Lu GL; Zhang L; Zhang X; Liu B; Seale H; Huang F; Wang QY
    Epidemiol Infect; 2011 Jan; 139(1):52-8. PubMed ID: 20854713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.